Bridging the Digital Divide in Pharmaceutical Tech Transfer
A summary of the full White Paper authored by Rob Innes and John Arthur of DTG with Mark Buswell and Nicola Clear of NGT BioPharma Consultants. Download the Full Report here Delays in tech transfer directly impact time-to-market – the single most important driver of commercial value in pharmaceutical development. So, with over one hundred […]